MLC Dx Lands $5,900,000 Series B Financing

  • Feed Type
  • Date
    8/13/2010
  • Company Name
    MLC Dx
  • Mailing Address
    Undisclosed San Francisco, CA 94134
  • Company Description
    The company is developing molecular diagnostic technologies.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,900,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Mohr Davidow Ventures
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.